-
No doubt you have scanned news reports of a recent study of male circumcision, used as an HIV prevention intervention, which resulted in dramatic reduction in HIV incidence among circumcised men.1 But does the news translate into an immediate change in public health policy?
-
The manufacturer of the abortion pill mifepristone (Mifeprex, Danco Laboratories; New York City) has revised the safety information for the drugs label and issued a letter to health care providers in light of five deaths from serious bacterial infection and sepsis following use of the medication abortion regimen.
-
New evidence indicates that women with benign breast disease have a higher risk for breast cancer, and that certain types of breast disease may predict the near-term development of breast cancer.
-
In reviewing the chart for your next patient, you note that she is a 28-year-old woman with epilepsy. What information do you need to provide her when it comes to contraceptive choices? Many family planning clinicians encounter this scenario. Epilepsy is one of the most common chronic health conditions affecting reproductive-age women.
-
Consider these facts: Women are the fastest-growing group in the United States with newly diagnosed HIV, and last year, an estimated 6,000-7,000 women with HIV gave birth.
-
-
The Centers for Medicare & Medicaid Services (CMS) has made sweeping changes to the Inpatient Prospective Payment System (IPPS) that will have a major impact on hospital reimbursement.
-
If youre not using your clinical pathways on a regular basis, youre missing an opportunity to facilitate the collection of quality indicators and outcomes information and to affect your patients length of stay.
-
Since Childrens National Medical Center in Washington, DC, implemented its diabetes clinical pathway, the hospitals average length of stay for diabetes patients has been significantly lower than the national average, and the 72-hour readmission rate has been less than 1%.
-
One of the better known ongoing collaborations in the United States is the Cambridge, MA-based Institute for Healthcare Improvements (IHI) 100,000 Lives Campaign, whose goal is to save 100,000 lives through targeted QI interventions by June 14, 2006.
